Biogen nominates mother of director’s child to replace him on board

‘We don’t agree’ on drug pricing, FDA chief tells biotech leaders

Eli Lilly’s Mounjaro succeeds in second weight-loss study

Kaiser Permanente to acquire Geisinger in blockbuster deal